Free Trial

Veracyte (VCYT) Earnings Date, Estimates & Call Transcripts

Veracyte logo
$28.10 +0.42 (+1.50%)
As of 10:43 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Veracyte Earnings Summary

Veracyte posted Q4 2024 earnings on February 24, 2025, reporting an EPS of $0.36, which topped the consensus estimate of $0.29 by $0.07. Quarterly revenue was reported to be $118.63 million, above the consensus estimate of $110.73 million. With a trailing EPS of $0.41 and a P/E Ratio of 85.24, Veracyte's earnings are expected to grow 5.88% next year, from $0.68 to $0.72 per share.

Latest Q4
Earnings Date
Feb. 24Estimated
Consensus EPS
(Feb. 24)
$0.29
Actual EPS
(Feb. 24)
$0.36 Beat By $0.07
Actual Revenue
(Feb. 24)
$118.63M

Q4 2024 Earnings Resources

Get Veracyte Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Veracyte and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

VCYT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VCYT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Veracyte Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue Guidance
Q1 20251$0.08$0.08$0.08
Q2 20252$0.19$0.24$0.22
Q3 20252$0.19$0.23$0.21
Q4 20252$0.23$0.25$0.24
FY 2025 7 $0.69 $0.80 $0.75
Q1 20261$0.13$0.13$0.13
Q2 20261$0.21$0.21$0.21
Q3 20261$0.23$0.23$0.23
Q4 20261$0.31$0.31$0.31

Veracyte Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
2/24/2025Q4 2024$0.29$0.36+$0.07$0.06$110.73M$118.63M
11/6/2024Q3 2024$0.03$0.19+$0.16$0.19$109.81M$115.86M
8/6/2024Q2 2024-$0.03$0.07+$0.10$0.53$100.27M$114.43M
5/7/2024Q1 2024-$0.19-$0.02+$0.17-$0.02$93.35M$96.84M
2/22/2024Q4 2023-$0.07-$0.04+$0.03$0.31$95.49M$98.20M
11/7/2023Q3 2023-$0.16-$0.03+$0.13$0.35$84.78M$90.11M
8/8/2023Q2 2023-$0.16-$0.12+$0.04-$0.12$83.05M$90.32M

Veracyte Earnings - Frequently Asked Questions

Veracyte (NASDAQ:VCYT) last announced its quarterly earning data on Monday, February 24, 2025. Learn more on VCYT's earnings history.

Veracyte updated its FY 2025 earnings guidance on Thursday, August, 7th. The company issued revenue guidance of $496.0 million-$504.0 million, compared to the consensus revenue estimate of $491.9 million.

In the previous quarter, Veracyte (NASDAQ:VCYT) reported $0.36 earnings per share (EPS) to beat the analysts' consensus estimate of $0.29 by $0.07. Learn more on analysts' earnings estimate vs. VCYT's actual earnings.

The conference call for Veracyte's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Veracyte's latest earnings report can be read online.
Read Transcript

Veracyte's earnings report can be found in their filing with the SEC.
View SEC filing

Veracyte (NASDAQ:VCYT) has a recorded annual revenue of $445.76 million.

Veracyte (NASDAQ:VCYT) has a recorded net income of $24.14 million. VCYT has generated $0.41 earnings per share over the last four quarters.

Veracyte (NASDAQ:VCYT) has a trailing price-to-earnings ratio of 83.88 and a forward price-to-earnings ratio of 40.71.

Veracyte's earnings are expected to grow from $0.68 per share to $0.72 per share in the next year, which is a 5.88% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:VCYT) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners